Symbol="ARVN"
AssetType="Common Stock"
Name="Arvinas Inc"
Description="Arvinas, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery, development, and commercialization of therapies to break down disease-causing proteins. The company is headquartered in New Haven, Connecticut."
CIK="1655759"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="395 WINCHESTER AVE, 5 SCIENCE PARK, NEW HAVEN, CT, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="1456931000"
EBITDA="-296400000"
PERatio="None"
PEGRatio="None"
BookValue="8.68"
DividendPerShare="0"
DividendYield="0"
EPS="-5.78"
RevenuePerShareTTM="2.963"
ProfitMargin="-1.882"
OperatingMarginTTM="-1.911"
ReturnOnAssetsTTM="-0.152"
ReturnOnEquityTTM="-0.525"
RevenueTTM="158100000"
GrossProfitTTM="131400000"
DilutedEPSTTM="-5.78"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.612"
AnalystTargetPrice="64.78"
TrailingPE="-"
ForwardPE="17.7"
PriceToSalesRatioTTM="17.64"
PriceToBookRatio="3.129"
EVToRevenue="6.07"
EVToEBITDA="-2.861"
Beta="1.745"
num_52WeekHigh="57.96"
num_52WeekLow="21.21"
num_50DayMovingAverage="24.81"
num_200DayMovingAverage="29.7"
SharesOutstanding="53485000"
DividendDate="None"
ExDividendDate="None"
symbol="ARVN"
open="27.26"
high="28.68"
low="27.13"
price="28.21"
volume="368501.00"
latest_trading_day="2023-08-31"
previous_close="27.24"
change="0.97"
change_percent="3.5609%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="47"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="53"
Volume_recent_avg="432720"
Change_recent_avg="-0.01"
Delta_recent_avg="1.41"
Variance_recent_avg="0.71"
Change_ratio_recent_avg="-0.13"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="53"
Aroon_momentum_negative="47"
image_negative_thumbnail_id_1="1102"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0135.jpeg"
image_negative_thumbnail_id_2="1162"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0196.jpeg"
image_neutral_thumbnail_id_1="543"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0056.jpeg"
image_neutral_thumbnail_id_2="546"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0053.jpeg"
image_positive_thumbnail_id_1="609"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0099.jpeg"
image_positive_thumbnail_id_2="649"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0059.jpeg"
image_professor_thumbnail_id_1="1173"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0007.jpeg"
image_professor_thumbnail_id_2="1195"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0029.jpeg"
